Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning

Increasingly, the effectiveness of adjuvant chemotherapy agents for breast cancer has been related to changes in the genomic profile of tumors. We investigated correspondence between growth inhibitory concentrations of paclitaxel and gemcitabine (GI50) and gene copy number, mutation, and expression...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mol Oncol
Prif Awduron: Dorman, Stephanie N., Baranova, Katherina, Knoll, Joan H.M., Urquhart, Brad L., Mariani, Gabriella, Carcangiu, Maria Luisa, Rogan, Peter K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2015
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528934/
https://ncbi.nlm.nih.gov/pubmed/26372358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.07.006
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg